Transforming growth factor-β and interleukin-10 subvert alloreactive delayed type hypersensitivity in cardiac allograft acceptor mice

Transplantation

Volumn 69, Issue 7, 2000, Pages 1517-1520

  Bickerstaff, Alice A ^a,b   VanBuskirk, Anne M ^a   Wakely, Elaine ^a   Orosz, Charles G ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALLIUM NITRATE; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNE RESPONSE; IMMUNOREACTIVITY; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

EID: 0034656113     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200004150-00055     Document Type: Article

References (11)

1. Madsen JC, Peugh WN, Wood KJ, Morris PJ. The effect of anti-L3T4 monoclonal antibody treatment on first-set rejection of murine cardiac allografts. Transplantation 1987; 44 (6): 849.
2. Bushell A, Morris PJ, Wood KJ. Transplantation tolerance induced by antigen pretreatment and depleting anti-CD4 antibody depends on CD4+ T cell regulation during the induction phase of the response. Eur J Immunol 1995; 25: 2643.
3. Orosz CG, Wakely E, Bergese SD, et al. Prevention of murine cardiac allograft rejection with gallium nitrate: comparison with anti-CD4 mAb. Transplantation 1996; 61: 783.
4. Orosz CG, Wakely E, Sedmak DD, Bergese SD, VanBuskirk AM. Prolonged murine cardiac allograft acceptance. Characteristics of persistent active alloimmunity after treatment with gallium nitrate versus anti-CD4 monoclonal antibody. Transplantation 1997; 63: 1109.
5. VanBuskirk AM, Wakely ME, Sirak JH, Orosz CG. Patterns of allosensitization in allograft recipients: Long-term cardiac allograft acceptance is associated with active alloantibody production in conjunction with active inhibition of alloreactive delayed-type hypersensitivity. Transplantation 1998; 65 (8): 1115.
6. Corry R, Winn H, Ressell P. Primarily vascularized allografts of hearts in mice. Transplantation 1973; 16: 343.
7. Sirak J, Orosz CG, Wakely E, VanBuskirk AM. Alloreactive delayed-type hypersensitivity in graft recipients: complexity of responses and divergence from acute rejection. Transplantation 1997; 63: 1300.
8. Engers H, Thomas K, Cerottini JC, Brunner K. Generations of cytotoxic T lymphocytes in immune spleen cells to subcellular alloantigens. J Immunol 1975; 115: 356.
9. D'Orazio TJ, Niederkorn JY. A novel role for TGF-b and IL-10 in the induction of immune privilege. J Immunol 1998; 160: 2089.
10. 10. Wilbanks GA, Mammolenti M, Streilein JW. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta. Eur J Immunol 1998; 22 (1): 165.
11. Josien R, Douillard P, Guillot C, et al. A critical role for transforming growth factor-b in donor transfusion-induced allograft tolerance. J.Clin.Invest. 1998; 102 (11): 1920.